BIOMOTION PHARMA ApS: Financial statements 2015
CVR: 12928203
Source: annual report 2015, Danish Business Authority
01/10/2014 – 30/09/2015
BIOMOTION PHARMA ApS (CVR 12928203) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 3,018 and a net result of DKK -1,982 compared with DKK -999 the year before. Equity in the 2015 report amounted to DKK -999.
- Gross Profit
- DKK 3,018
- Profit/Loss
- DKK -1,982
- Equity
- DKK -999
- Total Assets
- DKK 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 3 t. | -2 t. | -999 | - |
| 2014 | - | -999 | -999 | 983 | - |
| 2013 | - | 3 t. | 3 t. | 2 t. | - |
| 2012 | - | 3 t. | 3 t. | -1 t. | - |
Official annual report
How creditworthy is BIOMOTION PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
BIOMOTION PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -999, and the net result was DKK -999.
About BIOMOTION PHARMA ApS
BIOMOTION PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company is in liquidation. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Michael Rasmussen. The company is owned by Michael Rasmussen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,000 and a net result of DKK -4,202 compared with DKK -6,460 the year before. Equity in the 2025 report amounted to DKK -892.